Newsroom
     

Press Releases

09.01.2010
Adimab Selected as Technology Pioneer 2011 by World Economic Forum
> download PDF

07.09.2010
Adimab Announces Fifth Major Pharmaceutical Partnership in First Year After Launch of Novel Antibody Discovery Platform
> download PDF

12.17.2009
Adimab Announces New Antibody Discovery Collaborations with Pfizer and an Unnamed Partner and Achievement of Milestones in Existing Partnerships with Roche and Merck
> download PDF

10.01.2009
Adimab Completes Series D Financing Led by Google Ventures
> download PDF

6.16.2009
Adimab Launches Novel Antibody Discovery Platform and Announces Discovery Programs with Merck and Roche
> download PDF

11.20.2008
Adimab, Inc. Announces Series C Financing
> download PDF

10.24.2008
Guy Van Meter joins Adimab, Inc. as Senior Director, Head of Business Development
> download PDF

08.07.2008
Joanne Sun, Ph.D. joins Adimab, Inc. as Director of Protein Analytics and High Throughput Purification
> download PDF

05.28.2008
Adimab, Inc expands Scientific Advisory Board with Dr. Sachdev Sidhu
> download PDF

03.25.2008
Adimab, Inc. announces Series B Financing - Polaris and SV Life Sciences co-lead the investment
> download PDF

02.04.2008
Piotr Bobrowicz, Ph.D. to join Adimab, Inc. as Associate Director of Strain Development
> download PDF

11.01.2007
Adimab Annouces Scientific Advisory Board members
> download PDF

09.17.2007
Adimab and DNA2.0 Enter Exclusive Antibody Discovery Relationship
> download PDF

07.26.2007
Adimab Acquires Rights to Genetastix Yeast Antibody Patents
> download PDF

07.23.07
Michael Feldhaus, Ph.D. to join Adimab, Inc. as Senior Director of Antibody Engineering
> download PDF

07.20.2007
Adimab, Inc. Secures Series A Financing from Polaris and SV Life Sciences
> download PDF

07.09.2007
Max Vásquez Ph.D. joins Adimab as Senior Director of Computational Biology
> download PDF

 

News Articles

BioWorld Today
> Adimab Signs Novartis in Fifth Antibody Deal

Xconomy
> Novartis Test Drives Adimab’s Drug Discovery Engine

BioWorld Today
> Adimab's Yeast-Based Antibody Platform Nabs Two More Deals

The In Vivo Blog
> For Adimab, Deals and Deal Milestone Payments Come in Twos

Xconomy
> Adimab Proves Fast Antibody Discovery Tool to Merck, Roche; Snags New Deal With Pfizer

Chemical & Engineering News
> Practical Platform

BioWorld Today
> Adimab Yeast-Based Platform Draws Big Pharma’s Attention

The In Vivo Blog
> Adimab Banks on the Value of Discovery

Xconomy
> Adimab Strikes Antibody-Discovery Deals with Merck and Roche

The In Vivo Blog
> Notes from BIO: Adimab Pulls Back the Curtain

BioCentury
> Adimab: Simplifying the antibody recipe

MIT News
> Adimab co-founder Prof. Dane Wittrup and Prof. Bruce Tidor, member of Adimab's Scientific Advisory Board, report the use of computational modeling to improve affinity maturation of antibodies

The In Vivo Blog
> Adimab gets backed by Polaris and SVLS

VentureBeat
> Adimab: A potential one-stop shop for    antibodies